CompoAtlas

PHARMORIX SYMFLORIZ-35 CAPSULE

PHARMORIX SYMFLORIZ-35 CAPSULE : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Registration number
MAL21106090NC
Type
Health supplement
Published status
PRODUCT APPROVED
Licence holder
PHARMORIX (M) SDN. BHD.
Manufacturer
BELIVE HEALTHCARE SDN. BHD.
Registration period starting
2026-10-28
Published validity end
2031-10-28

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
LACTOBACILLUS REUTERILACTOBACILLUS REUTERI[100 mg,480 mg]Not identified
FRUCTOOLIGOSACCHARIDESFRUCTOOLIGOSACCHARIDES[100 mg,480 mg]Not identified
LACTOBACILLUS RHAMNOSUSLACTOBACILLUS RHAMNOSUS[45 mg,480 mg]Not identified
BIFIDOBACTERIUM LONGUMBIFIDOBACTERIUM LONGUM[12.5 mg,480 mg]Not identified
LACTOBACILLUS CASEILACTOBACILLUS CASEI[15 mg,480 mg]Not identified
LACTOBACILLUS GASSERILACTOBACILLUS GASSERI[15 mg,480 mg]Not identified
LACTOBACILLUS PLANTARUMLACTOBACILLUS PLANTARUM[15 mg,480 mg]Not identified
BIFIDOBACTERIUM BREVEBIFIDOBACTERIUM BREVE[5 mg,480 mg]Not identified
LACTOBACILLUS PARACASEI SPP. PARACASEILACTOBACILLUS PARACASEI SPP. PARACASEI[5 mg,480 mg]Not identified
BIFIDOBACTERIUM BIFIDUMBIFIDOBACTERIUM BIFIDUM[5 mg,480 mg]Not identified
STREPTOCOCCUS THERMOPHILUSSTREPTOCOCCUS THERMOPHILUS[5 mg,480 mg]Not identified
LACTOBACILLUS ACIDOPHILUSLACTOBACILLUS ACIDOPHILUS[5 mg,480 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Active ingredients
LACTOBACILLUS REUTERI[100 mg,480 mg],FRUCTOOLIGOSACCHARIDES[100 mg,480 mg],LACTOBACILLUS RHAMNOSUS[45 mg,480 mg],BIFIDOBACTERIUM LONGUM[12.5 mg,480 mg],LACTOBACILLUS CASEI[15 mg,480 mg],LACTOBACILLUS GASSERI[15 mg,480 mg],LACTOBACILLUS PLANTARUM[15 mg,480 mg],BIFIDOBACTERIUM BREVE[5 mg,480 mg],LACTOBACILLUS PARACASEI SPP. PARACASEI[5 mg,480 mg],BIFIDOBACTERIUM BIFIDUM[5 mg,480 mg],STREPTOCOCCUS THERMOPHILUS[5 mg,480 mg],LACTOBACILLUS ACIDOPHILUS[5 mg,480 mg]
Valid until
2031-10-28
Registration date
2026-10-28
Published description
HEALTH SUPPLEMENT
Licence holder
PHARMORIX (M) SDN. BHD.
Producer
BELIVE HEALTHCARE SDN. BHD.
Published name
PHARMORIX SYMFLORIZ-35 CAPSULE
Published reference
202108135860N
Registration number
MAL21106090NC
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL21106090NC

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line